Sign In
Buy VIVXF
$0.0001
+0 (+0%)
At Close: Jun 22, 2026
High Tide (NASDAQ:HITI) and Avivagen (OTCMKTS:VIVXF) Financial Comparison
02:46am, Wednesday, 25'th Mar 2026
Avivagen (OTCMKTS:VIVXF - Get Free Report) and High Tide (NASDAQ: HITI - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the
Contrasting Avivagen (OTCMKTS:VIVXF) & Stryker (NYSE:SYK)
03:39am, Friday, 20'th Feb 2026
Stryker (NYSE: SYK - Get Free Report) and Avivagen (OTCMKTS:VIVXF - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the s
Avivagen Makes Voluntary Assignment into Bankruptcy Under the BIA
04:04pm, Wednesday, 24'th Apr 2024
Ottawa, Ontario--(Newsfile Corp. - April 24, 2024) - Avivagen Inc. (TSXV: VIV) ("Avivagen" or the "Company"), a life sciences corporation focused on developing and commercializing products for livesto
Avivagen Announces New 500Kg Order for OxC-beta™
08:38am, Tuesday, 17'th Oct 2023
OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV.VIV) (“Avivagen” or the “Company”), a life sciences corporation focused on developing and commercializing products for livestock, companio
Avivagen Inc. Announces Results for the Third Quarter Ending July 31, 2023
08:13am, Friday, 29'th Sep 2023
OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV:VIV) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human ap
Avivagen Provides Corporate Updates
04:56pm, Monday, 31'st Jul 2023
OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV.VIV) (“Avivagen” or the “Company”), a life sciences corporation focused on developing and commercializing products for livestock, companio
Avivagen Announces New Orders for 1.1 Tonnes of Oxc-Beta™ Livestock Product
07:00am, Monday, 24'th Jul 2023
OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV.VIV) (“Avivagen” or the “Company”), a life sciences corporation focused on developing and commercializing products for livestock, companio
Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants
04:05pm, Friday, 11'th Jun 2021
OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal
Avivagen Inc. Announces Results for the Second Quarter Ending April 30, 2021
04:30pm, Wednesday, 02'nd Jun 2021
OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal
Avivagen Announces Largest Single Customer Purchase Order
06:30am, Friday, 23'rd Apr 2021
OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal
Avivagen Inc. to Issue Shares to Holders of Debentures in Lieu of Annual Maintenance Fee
06:30am, Friday, 09'th Apr 2021
OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”) announces that a total of 3,931 common shares will be issued at the rate of $0.58 per
Avivagen Discusses Significant Purchase Orders for OxC-beta(TM) Livestock with The Stock Day Podcast
09:06am, Tuesday, 06'th Apr 2021
Phoenix, Arizona--(Newsfile Corp. - April 6, 2021) - The Stock Day Podcast welcomed Avivagen (OTCQB: VIVXF) ("the Company"), a life sciences corporation focused on developing and commercializing produ
